Unknown PHASE2 INTERVENTIONAL 2-arm NCT00723268

Evaluation of Therapeutic Effect of 0.5 mg Colchicine and 5 mg Prednisolone on Oral Aphthae

Sponsor: Mashhad University of Medical Sciences

Updated 6 times since 2017 Last updated: Jul 28, 2008 Started: May 31, 2007 Primary completion: Aug 31, 2008

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on Oral Aphthae, this trial is ongoing. The trial is conducted by Mashhad University of Medical Sciences and has accumulated 6 data snapshots since 2007. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

6 versions recorded

Sep 2025 — Present [monthly]

Unknown PHASE2
Sep 2024 — Sep 2025 [monthly]

Unknown PHASE2
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE2

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE2
Jun 2018 — Jan 2021 [monthly]

Unknown Status PHASE2

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Unknown Status PHASE2

First recorded

May 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Mashhad University of Medical Sciences
University of Tehran

Data source: Mashhad University of Medical Sciences

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Mashhad, Iran